author-photo

Barnaby Hunt

86

Papers

559

Citations

Citation Trend

Filter By

Papers (65) Sort By

Journal Conference Others

A Response to: Letter to the Editor Regarding 'Iron Formulations for the Treatment of Iron Deficiency Anemia in Patients with Inflammatory Bowel Disease: A Cost-Effectiveness Analysis in Switzerland'.

2021 Advances in Therapy
Show All
- Source
- Cite
- Save
Citations (0)
Evaluating the Cost-Effectiveness of Once-Weekly Semaglutide 1 mg Versus Empagliflozin 25 mg for Treatment of Patients with Type 2 Diabetes in the UK Setting.

2021 Diabetes Therapy
Show All
- Source
- Cite
- Save
Citations (2)
PDB42 Evaluating the Cost-Effectiveness of Once-Weekly Semaglutide 1 MG Versus Empagliflozin 25 MG for Treatment of Patients with Type 2 Diabetes in the UK Setting

2020 Value in Health
Show All
- Source
- Cite
- Save
Citations (0)
PSY4 Evaluation of the Cost-Effectiveness of Iron Formulations for the Treatment of Iron Deficiency Anaemia in Patients with Inflammatory Bowel Disease in the UK

2020 Value in Health
Show All
- Source
- Cite
- Save
Citations (0)
Iron Formulations for the Treatment of Iron Deficiency Anemia in Patients with Inflammatory Bowel Disease: A Cost-Effectiveness Analysis in Switzerland.

2020 Advances in Therapy
Show All
- Source
- Cite
- Save
Citations (4)
The Short-Term Cost-Effectiveness of Once-Weekly Semaglutide Versus Once-Daily Sitagliptin and Once-Weekly Dulaglutide for the Treatment of Patients with Type 2 Diabetes: A Cost of Control Analysis in Spain.

2020 Diabetes Therapy
Show All
- Source
- Cite
- Save
Citations (3)
PDB41 HOW MUCH DOES THERAPEUTIC INERTIA IN TYPE 2 DIABETES COST THE UK? A MODELING EVALUATION OF ECONOMIC BURDEN

2020 Value in Health
Show All
- Source
- Cite
- Save
Citations (0)
Evaluation of the Long-Term Cost-Effectiveness of Once-Weekly Semaglutide Versus Dulaglutide and Sitagliptin in the Spanish Setting.

2020 Advances in Therapy
Show All
- Source
- Cite
- Save
Citations (2)
Oral Semaglutide Versus Empagliflozin, Sitagliptin and Liraglutide in the UK: Long-Term Cost-Effectiveness Analyses Based on the PIONEER Clinical Trial Programme

2020 Diabetes Therapy
Show All
- Source
- Cite
- Save
Citations (14)
PDB54 EVALUATING THE IMPACT OF POOR GLYCEMIC CONTROL ASSOCIATED WITH THERAPEUTIC INERTIA ON LIFE EXPECTANCY IN PATIENTS WITH TYPE 2 DIABETES IN THE UK

2020 Value in Health
Show All
- Source
- Cite
- Save
Citations (0)